Literature DB >> 30830294

Disparity in age at lung cancer diagnosis between current and former smokers.

Barbara G Campling1, Zhong Ye2, Yinzhi Lai2, Ling Li2, Voichita Bar-Ad3, Maria Werner-Wasik3, Bo Lu3, Scott W Cowan4, Nathaniel R Evans4, Inna Chervoneva5, Chun Wang6.   

Abstract

PURPOSE: In a previous study of smoking cessation in veterans with lung cancer, we noted as an incidental finding that current smokers were much younger than former smokers at diagnosis. To confirm and extend this observation, we analyzed the association of smoking status with age at diagnosis and survival of lung cancer patients.
METHODS: The Jefferson Cancer Registry collects information on all cancer patients registered at this hospital. Information on smoking status has been recorded since 1995. We determined age at diagnosis and survival of current and former smokers with lung cancer.
RESULTS: 5111 lung cancer cases were identified in the registry from 1995 to 2011 inclusive. Smoking status was recorded in 4687 cases (91.7%). Of these, 1859 (39.7%) were current, 2423 (51.7%) were former, and 405 (8.6%) were never smokers. There was a 6-year difference in median age at lung cancer diagnosis between the current (63 years) and former smokers (69 years) (P < 0.0001). The median survival was 12.1 months for current versus 14.5 months for former smokers (P < 0.0001).
CONCLUSIONS: These results confirm and extend our observation that among patients diagnosed with lung cancer, current smokers are younger than former smokers. The possible explanations include higher competing causes of death and increased risk of lung cancer among current smokers as well as increasing proportions of former smokers in older populations. Ongoing exposure to tobacco carcinogens may accelerate the development of lung cancer in continuing smokers. This provides more incentive for smokers to quit at the earliest age possible.

Entities:  

Keywords:  Age disparity; Cancer registry; Lung neoplasms; Smoking; Smoking cessation

Mesh:

Year:  2019        PMID: 30830294     DOI: 10.1007/s00432-019-02875-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  3 in total

1.  A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway.

Authors:  Xianyu Zhang; Huan Ma; Xiurong Lu; Zhilin Zhang
Journal:  J Healthc Eng       Date:  2022-03-15       Impact factor: 2.682

2.  Lung cancer in young patients: tumour characteristics and treatment in an Irish population.

Authors:  Sarah Cullivan; Sarah Ni Mhaolcatha; Michael T Henry; Nazri Kaderi Muhammad; William Mullally; Richard M Bambury; Louise Burke; Marcus P Kennedy
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

3.  Using Population-Based Cancer Registration Data and Period Analysis to Accurately Assess and Predict 5-Year Relative Survival for Lung Cancer Patients in Eastern China.

Authors:  Runhua Li; Min Zhang; Yongran Cheng; Xiyi Jiang; Huijuan Tang; Liangyou Wang; Tianhui Chen; Bicheng Chen
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.